Target Price | $47.70 |
Price | $36.49 |
Potential | 30.71% |
Number of Estimates | 23 |
23 Analysts have issued a price target Baker Hughes 2026 . The average Baker Hughes target price is $47.70. This is 30.71% higher than the current stock price. The highest price target is $56.00 53.47% , the lowest is $39.00 6.88% . | |
A rating was issued by 29 analysts: 24 Analysts recommend Baker Hughes to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Baker Hughes stock has an average upside potential 2026 of 30.71% . Most analysts recommend the Baker Hughes stock at Purchase. |
22 Analysts have issued a sales forecast Baker Hughes 2025 . The average Baker Hughes sales estimate is $27.1b . This is 2.76% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $27.8b 0.29% , the lowest is $26.4b 5.01% .
This results in the following potential growth metrics:
2024 | $27.8b | 9.11% |
---|---|---|
2025 | $27.1b | 2.73% |
2026 | $28.0b | 3.35% |
2027 | $28.7b | 2.48% |
2028 | $29.0b | 1.01% |
2029 | $27.8b | 4.12% |
23 Analysts have issued an Baker Hughes EBITDA forecast 2025. The average Baker Hughes EBITDA estimate is $4.7b . This is 1.28% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 7.34% , the lowest is $4.5b 3.27% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.5b | 21.22% |
---|---|---|
2025 | $4.7b | 3.39% |
2026 | $5.1b | 8.55% |
2027 | $5.3b | 5.28% |
2028 | $5.6b | 4.37% |
2029 | $5.3b | 5.51% |
2024 | 16.23% | 11.10% |
---|---|---|
2025 | 17.26% | 6.31% |
2026 | 18.13% | 5.04% |
2027 | 18.62% | 2.70% |
2028 | 19.24% | 3.33% |
2029 | 18.96% | 1.46% |
10 Baker Hughes Analysts have issued a net profit forecast 2025. The average Baker Hughes net profit estimate is $2.3b . This is 21.63% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.5b 13.99% , the lowest is $2.1b 26.62% .
This results in the following potential growth metrics and future Net Margins:
2024 | $3.0b | 56.02% |
---|---|---|
2025 | $2.3b | 22.94% |
2026 | $2.7b | 17.96% |
2027 | $3.0b | 10.04% |
2024 | 10.61% | 43.00% |
---|---|---|
2025 | 8.40% | 20.79% |
2026 | 9.59% | 14.17% |
2027 | 10.30% | 7.40% |
10 Analysts have issued a Baker Hughes forecast for earnings per share. The average Baker Hughes EPS is $2.30 . This is 21.50% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.52 13.99% , the lowest is $2.15 26.62% .
This results in the following potential growth metrics and future valuations:
2024 | $2.98 | 56.02% |
---|---|---|
2025 | $2.30 | 22.82% |
2026 | $2.71 | 17.83% |
2027 | $2.98 | 9.96% |
Current | 12.38 | 30.14% |
---|---|---|
2025 | 15.79 | 27.54% |
2026 | 13.38 | 15.26% |
2027 | 12.16 | 9.12% |
Based on analysts' sales estimates for 2025, the Baker Hughes stock is valued at an EV/Sales of 1.39 and an P/S ratio of 1.33 .
This results in the following potential growth metrics and future valuations:
Current | 1.35 | 3.05% |
---|---|---|
2025 | 1.39 | 3.05% |
2026 | 1.35 | 3.24% |
2027 | 1.31 | 2.42% |
2028 | 1.30 | 1.00% |
2029 | 1.36 | 4.31% |
Current | 1.29 | 6.14% |
---|---|---|
2025 | 1.33 | 2.84% |
2026 | 1.28 | 3.24% |
2027 | 1.25 | 2.42% |
2028 | 1.24 | 1.00% |
2029 | 1.29 | 4.30% |
Analyst | Rating | Action | Date |
---|---|---|---|
Susquehanna |
Positive
➜
Positive
|
Unchanged | Apr 24 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 24 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Apr 24 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 24 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Apr 24 2025 |
TD Securities |
Buy
➜
Buy
|
Unchanged | Apr 24 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 24 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Susquehanna:
Positive
➜
Positive
|
Apr 24 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 24 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 24 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 24 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Apr 24 2025 |
Unchanged
TD Securities:
Buy
➜
Buy
|
Apr 24 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.